KucukseymenS. Inflammation effect on stent restenosis. Angiology. 2017. doi:10.1177/0003319717701659.
2.
UekiYMiuraTMiyashitaY. et al. Inflammatory cytokine levels after endovascular therapy in patients with peripheral artery disease. Angiology. 2016. pii:0003319716682122.
3.
IidaOTakaharaMSogaY. et al. 1-year results of the ZEPHYR registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): predictors of restenosis. JACC Cardiovasc Interv. 2015;8(8):1105–1112.
4.
IidaOSogaYHiranoK. et al. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis. J Endovasc Ther. 2011;18(6):753–761.
5.
MevesSHDiehmCBergerK. et al. Peripheral arterial disease as an independent predictor for excess stroke morbidity and mortality in primary-care patients: 5-year results of the getABI study. Cerebrovasc Dis. 2010;29(6):546–554.
6.
StegPGBhattDLWilsonPW. et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297(11):1197–1206.
7.
NorgrenLHiattWRDormandyJANehlerMRHarrisKAFowkesFG; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5–S67.
